Adamantano, mínimo 99 %, para síntesis, 25 g, envase de vidrio

3-Amino-6-bromopicolinic acid, 95.0%, 5g

6-Methyl-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid hydrochloride, 96%, 1g

2-Bromo-5-(trifluoromethyl)benzodifluoride (stabilized over Potassium carbonate), 250mg

4-Chlorophenyl cyclobutyl ketone, 97.0%, 100mg

3-Bromocyclopentane-1-carboxylic acid, 97%, 5g

2,2,2-Trifluoro-1-(4-nitrophenyl)ethanone, 95.0%, 100mg

4-Pyrazol-1-yl-benzaldehyde, 95.0%, 25g

1-(tert-Butyl) 3-ethyl 4-amino-5,6-dihydropyridine-1,3(2H)-dicarboxylate, 97%, 5g

3-BROMO-6-CYCLOPROPYLPYRIDAZINE HYDROBROMIDE, 95.0%, 5g

1-(Trifluoromethyl)ethylamine, 98.0%, 2.5g

(R,E)-3-(1-Methylpyrrolidin-2-yl)acrylic acid, 97%, 250mg

C-[5-(3-Trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-yl]-methylamine; hydrochloride, 95.0%, 1g